ME Therapeutics Holdings Inc. Share Price
Equities
METX
CA5527671054
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 CAD | -19.03% | +0.25% | +233.33% |
1 day | -19.03% | ||
1 week | +0.25% | ||
Current month | -19.19% | ||
1 month | +1.01% | ||
3 months | +33.33% | ||
6 months | +3,900.00% | ||
Current year | +233.33% |
Managers | Title | Age | Since |
---|---|---|---|
Salim Dhanji
CEO | Chief Executive Officer | 44 | 09/23/09 |
Quinn Martin
DFI | Director of Finance/CFO | 42 | 09/23/09 |
Jamil Kassam
SEC | Corporate Secretary | 44 | 09/23/09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karim Nanji
BRD | Director/Board Member | 57 | 07/23/07 |
Salim Dhanji
CEO | Chief Executive Officer | 44 | 09/23/09 |
Kenneth Harder
BRD | Director/Board Member | 57 | 09/23/09 |
1st Jan change | Capi. | |
---|---|---|
+233.33% | 85.7M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- METX Stock